New therapies and how the medical community sequences these new therapies are having a dramatic impact on prostate cancer survival rates, says Daniel J. George, MD, director of the Prostate Urologic Cancers Program, Duke University Cancer Institute.
Dramatic Survival Benefits
25 February 2020, 2:30 EST
